Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
- Conditions
- InfectionClostridium Difficile InfectionCommunicable Diseases
- Interventions
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Rebiotix Inc.
- Target Recruit Count
- 793
- Registration Number
- NCT03931941
- Locations
- 🇺🇸
Phoenix, Phoenix, Arizona, United States
🇺🇸North Little Rock, North Little Rock, Arkansas, United States
🇺🇸Oxnard, Oxnard, California, United States
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
- Conditions
- Clostridium Difficile Infection (CDI)
- Interventions
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Rebiotix Inc.
- Target Recruit Count
- 320
- Registration Number
- NCT03244644
- Locations
- 🇺🇸
Athens, Athens, Alabama, United States
🇺🇸Dothan, Dothan, Alabama, United States
🇺🇸Phoenix, Phoenix, Arizona, United States
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
- Conditions
- Clostridium Difficile Infection
- Interventions
- Biological: RBX2660Drug: Standard of Care Antibiotics
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Rebiotix Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT02589847
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
- Conditions
- Enterocolitis Clostridium Difficile Recurrent
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Rebiotix Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02299570
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
🇺🇸Borland-Groover Clinic, Jacksonville, Florida, United States
Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea
- Conditions
- Recurrent Clostridium Difficile Infection
- First Posted Date
- 2013-08-19
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Rebiotix Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT01925417
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸Denver Health and University of Colorado, Denver, Colorado, United States
🇺🇸Borland-Groover Clinic, Jacksonville, Florida, United States